Project Grant R03AG095673
- The General Hospital Corporation's Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $474,783 federal Project Grant (R56AT011869) from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310). The award supports the adaptation and pilot testing of a remote mind-body resiliency group intervention to promote resilience among English and Spanish-speaking parents of children with learning and attentional disabilities...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $372,307 Project Grant award from the U.S. Department of Health and Human Services' Fogarty International Center (CFDA 93.989 - International Research and Research Training) on September 9, 2025. The grant supports a collaborative project with the Ignace Hospital in Guinea and three rural Guinea sites to build capacity for the diagnosis and treatment of neuromyelitis optica (NMO) using...
- This $629,562 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. The grant will support comprehensive scientific research to investigate the role of mechanical stiffening ("mechanoaging") of the intestine in the deterioration of intestinal homeostasis and barrier integrity with age. The research aims to elucidate the fundamental...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- This federal Project Grant award, valued at $453,750.00 and effective September 1, 2025, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a research program led by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to advance the understanding of perioperative neurocognitive disorders (PND) and their association with disruptions in...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $819,980.00 in funding to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on elucidating sex differences in melanoma tumorigenesis. The 3-year research project, beginning on August 15, 2024 and ending on August 14, 2027, aims to advance the understanding and treatment of this complex...
- This federal Project Grant award for $412,500.00, provided by the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 - Biomedical Research and Research Training program, supports a research program to improve the interpretation of rare genetic variants. The awardee, The General Hospital Corporation doing business as Massachusetts General Hospital (MGH), will use state-of-the-art computational methods to enhance existing annotation tools for predicting the impact of...
- The General Hospital Corporation, doing business as Massachusetts General Hospital, received a $587,117 project grant from the Defense Health Agency's Military Medical Research and Development program to develop an online platform promoting evidence-based care for patients with neurofibromatosis 1. The three-year grant, awarded June 1, 2023 and set to be completed by May 31, 2026, aims to address medical and social barriers to care through tailoring an online resource to provide specialized...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,485,000 Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award period runs from September 1, 2025 to August 31, 2028. The grant supports research focused on the discovery and characterization of programmable biological systems, particularly new RNA-guided functions found in...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $129,330 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on profiling and forecasting individual progression in Alzheimer's disease and related dementias (ADRD). The key objectives of this 5-year project are to: 1) deploy a multi-modal information framework that leverages decades-long in vivo and digital...
The General Hospital Corporation, doing business as Massachusetts General Hospital, received a $412,500 project grant award from the National Institute on Aging (CFDA 93.866 Aging Research) to explore serious illness communication between Latino Spanish-speaking older adults and community-based palliative care clinicians. The project aims to address critical gaps in serious illness communication for this population, including clinicians' barriers to initiating these conversations and the challenges of language discordance. This research builds on the awardee's prior work studying serious illness communication experiences of hospitalized Latino patients and inpatient palliative care clinicians. The project will run from September 2025 through August 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $412.5k | 9/9/25 |